Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan. (Q48358275)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 September 2012

Language	Label	Description	Also known as
English	Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.	scientific article published on 7 September 2012

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

1 reference

based on heuristic

inferred from title

author name string

Akemi Tanaka

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Torayuki Okuyama

2

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Yasuyuki Suzuki

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Norio Sakai

4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Hiromitsu Takakura

5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Tomo Sawada

6

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Toju Tanaka

7

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Takanobu Otomo

8

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Toya Ohashi

9

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Mika Ishige-Wada

10

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Hiromasa Yabe

11

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Toshihiro Ohura

12

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Nobuhiro Suzuki

13

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Koji Kato

14

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Souichi Adachi

15

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Ryoji Kobayashi

16

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Hideo Mugishima

17

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Shunichi Kato

18

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

publication date

7 September 2012

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

107

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

513-520

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Mucopolysaccharidosis I: management and treatment guidelines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Bone marrow transplantation in Hunter syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Long-term follow-up following bone marrow transplantation for Hunter disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Evaluation of ADL in patients with Hunter disease using FIM score.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

LEFT RETROGRADE CARDIOANGIOGRAPHY IN ACQUIRED CARDIAC DISEASE: TECHNIC, INDICATIONS AND INTERPRETATIONS IN 700 CASES

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Long-term adaptive functioning outcomes of children with inherited metabolic and genetic diseases treated with hematopoietic stem cell transplantation in a single large pediatric center: parents' perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Emerging trends in transplantation of inherited metabolic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

Long-term effects of bone marrow transplantation for inborn errors of metabolism: a study of four patients with lysosomal storage diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMGME.2012.09.004

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/23022072

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48358275&oldid=1874255927"